The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in adults with solid tumor malignancy (STM).
K. M. Mullane
Research Funding - Merck Sharp & Dohme
M. R. Mullane
Research Funding - Merck Sharp & Dohme
B. M. Y. Wong
Research Funding - Merck Sharp & Dohme (B)
Y. Zhao
Employment or Leadership Position - Merck Sharp & Dohme
Stock Ownership - Merck Sharp & Dohme (B)
T. Sterling
Employment or Leadership Position - Merck Sharp & Dohme
Stock Ownership - Merck Sharp & Dohme
S. Manoff
Employment or Leadership Position - Merck Sharp & Dohme
Stock Ownership - Merck Sharp & Dohme
P. W. Annunziato
Employment or Leadership Position - Merck Sharp & Dohme
Stock Ownership - Merck Sharp & Dohme